Bausch Health Companies shares are trading higher after RBC Capital raised its price target on the stock from $10 to $11.
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies shares are trading higher following RBC Capital's decision to raise its price target from $10 to $11.
November 01, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has increased its price target for Bausch Health Companies from $10 to $11, leading to a rise in the company's stock price.
The increase in the price target by RBC Capital is a positive signal to investors, suggesting confidence in Bausch Health's future performance. This has led to an immediate positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100